Home›Companies›Biotech & Pharma›Phantom Neuro

Phantom Neuro Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 18, 2025·Suggest an edit

About Phantom Neuro

Phantom Neuro is a private company based in Austin, Texas, incorporated in 2020 in Delaware. It has reported $15,357,138 raised in two offerings on Form D since March 2022. Its chief executive is Connor Glass.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 7, 2025Mar 18, 2025$12,097,140of $19.2M target22$549KEquityRule 506(b)Form D ↗
Mar 11, 2022Mar 25, 2022$3,259,998fully sold6$543KEquityRule 506(b)Form D ↗
Total, two offerings$15,357,138

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Phantom Neuro's Form D filed Mar 18, 2025.

CG
Connor Glass
Chief Executive Officer and director
DW
D.a. Wallach
Director
EM

Earlier filings also listed Robert Lord (director, last listed Mar 2022).

Sources

  1. SECPhantom Neuro Inc. filing history